Trials / Terminated
TerminatedNCT00672945
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
Phase 2 Double-Blind Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- Sponsor
- Epix Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week double-blind treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRX-03140 | |
| DRUG | Placebo |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-01-01
- First posted
- 2008-05-06
- Last updated
- 2009-07-30
Locations
38 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00672945. Inclusion in this directory is not an endorsement.